Li-Qun Fan

Title: Li-Qun Fan: Innovator in Gene Expression Markers

Introduction

Li-Qun Fan is a notable inventor based in Bellevue, WA (US). She has made significant contributions to the field of gene expression profiling, particularly in the context of cancer treatment. Her work focuses on identifying biomarkers that can predict patient outcomes, which is crucial for personalized medicine.

Latest Patents

Li-Qun Fan holds a patent titled "Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T." This patent involves a method for gene expression profiling in patients with metastatic castration-resistant prostate cancer (mCRPC). The method includes determining the gene expression levels of specific biomarkers and transforming these levels into a score that corresponds to the probability of overall survival in response to treatment with sipuleucel-T.

Career Highlights

Li-Qun Fan is associated with Dendreon Pharmaceuticals LLC, where she applies her expertise in biomarker research. Her innovative approach has the potential to enhance treatment strategies for patients undergoing therapy with sipuleucel-T.

Collaborations

Li-Qun Fan collaborates with various professionals in her field, including her coworker James B Trager. Their combined efforts contribute to advancing research in gene expression and cancer treatment.

Conclusion

Li-Qun Fan's work in gene expression markers represents a significant advancement in predicting patient outcomes in cancer therapy. Her contributions are vital for the future of personalized medicine and improving survival rates for patients.